MedTrace Logo

The Influence of Red Grape Cells on Blood Pressure Vascular Function in People With Hypertension

NCT01146470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-02-20

No results posted yet for this study

Summary

The study hypothesis is that 3 Months Daily Supplementation of RGC will effect blood pressure and vascular function.

This will be a single-center, double-blind, random, parallel controlled Study. Study population will include 60 subjects, who will be divided randomly into three groups. The first group will get RGC 200mg, the second group will get RGC 400mg, and the third group will get 200mg placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

RGC

dosage of Red Grape Cells once a day, during 3 months

DIETARY_SUPPLEMENT

Placebo

dosage of Placebo once a day, during 3 months

Sponsors & Collaborators

  • Fruitura Bioscience Ltd.

    collaborator INDUSTRY

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Nachum Vaisman, Professor · Tel-Aviv Sourasky Medical Center, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01146470 on ClinicalTrials.gov